Cargando…
Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial
BACKGROUND: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and effective for sudden cardiac death prevention. However, patients in previous S-ICD studies had fewer comorbidities, had less left ventricular dysfunction, and received more inappropriate shocks (IAS) than in ty...
Autores principales: | Gold, Michael R., Lambiase, Pier D., El-Chami, Mikhael F., Knops, Reinoud E., Aasbo, Johan D., Bongiorni, Maria Grazia, Russo, Andrea M., Deharo, Jean-Claude, Burke, Martin C., Dinerman, Jay, Barr, Craig S., Shaik, Naushad, Carter, Nathan, Stoltz, Thomas, Stein, Kenneth M., Brisben, Amy J., Boersma, Lucas V.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752215/ https://www.ncbi.nlm.nih.gov/pubmed/33073614 http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048728 |
Ejemplares similares
-
The Subcutaneous ICD: A Review of the UNTOUCHED and PRAETORIAN Trials
por: Karimianpour, Ahmadreza, et al.
Publicado: (2021) -
Real‐world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD
por: Baalman, Sarah W.E., et al.
Publicado: (2020) -
Untouched
por: Ray, Animesh
Publicado: (2021) -
Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022) -
Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
por: Lambiase, Pier D., et al.
Publicado: (2020)